About EvolutionaryScale
EvolutionaryScale is a company based in New York (United States) founded in 2023 by Thomas Hayes, Tom Sercu, Halil Akin, Roshan Rao, and Alexander Rives.. EvolutionaryScale has raised $142 million across 1 funding round from investors including Amazon, Nat Friedman and Daniel Gross. EvolutionaryScale operates in a competitive market with competitors including Nimbus Therapeutics, Cradle, Evozyne, Profluent Bio and Frontier Medicines, among others.
- Headquarter New York, United States
- Founders Thomas Hayes, Tom Sercu, Halil Akin, Roshan Rao, Alexander Rives
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sinapsis Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$142 M (USD)
in 1 rounds
-
Latest Funding Round
$142 M (USD), Seed
Jun 25, 2024
-
Investors
Amazon
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of EvolutionaryScale
EvolutionaryScale has successfully raised a total of $142M through 1 strategic funding round. The most recent funding activity was a Seed round of $142 million completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $142.0M
-
First Round
First Round
(25 Jun 2024)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2024 | Amount | Seed - EvolutionaryScale | Valuation | Nat Friedman , Daniel Gross |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in EvolutionaryScale
EvolutionaryScale has secured backing from 5 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include Amazon, Nat Friedman and Daniel Gross. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed and early-stage technology companies are funded by Lux Capital.
|
Founded Year | Domain | Location | |
|
Venture capital arm of Nvidia
|
Founded Year | Domain | Location | |
|
Multi-category products are offered through an online marketplace.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by EvolutionaryScale
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - EvolutionaryScale
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Evolutionaryscale Comparisons
Competitors of EvolutionaryScale
EvolutionaryScale operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nimbus Therapeutics, Cradle, Evozyne, Profluent Bio and Frontier Medicines, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Chemoproteomics solutions are provided for protein design and development.
|
|
| domain | founded_year | HQ Location |
Developer of proteins using protein engineering technology
|
|
| domain | founded_year | HQ Location |
An AI-based protein design platform is provided for drug discovery.
|
|
| domain | founded_year | HQ Location |
Bioinformatics platform is developed for drug discovery and chemoproteomics.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Evolutionaryscale
Frequently Asked Questions about EvolutionaryScale
When was EvolutionaryScale founded?
EvolutionaryScale was founded in 2023 and raised its 1st funding round 1 year after it was founded.
Where is EvolutionaryScale located?
EvolutionaryScale is headquartered in New York, United States. It is registered at New York, New York, United States.
Who is the current CEO of EvolutionaryScale?
Alexander Rives is the current CEO of EvolutionaryScale. They have also founded this company.
Is EvolutionaryScale a funded company?
EvolutionaryScale is a funded company, having raised a total of $142M across 1 funding round to date. The company's 1st funding round was a Seed of $142M, raised on Jun 25, 2024.
What does EvolutionaryScale do?
EvolutionaryScale was founded in 2023 and is headquartered in New York, United States. Operations focus on the biotechnology sector, where AI-driven models for protein engineering are provided. The companys ESM3 model is utilized to analyze protein sequences, structures, and functions simultaneously. Services support research in biological applications, with a team of co-founders leading development efforts.
Who are the top competitors of EvolutionaryScale?
EvolutionaryScale's top competitors include Nimbus Therapeutics, Cradle and Profluent Bio.
Who are EvolutionaryScale's investors?
EvolutionaryScale has 5 investors. Key investors include Amazon, Nat Friedman, Daniel Gross, Lux Capital, and NVentures.